VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM OR CEFEPIME AND SEPSIS-ASSOCIATED AKI TRAJECTORY

被引：0
|
作者：
Behal, Michael [1 ]
Whitenack, Kaylee [2 ]
Bastin, Melissa Thompson [3 ]
Adams, Paul [1 ]
Aycinena, Juan Carlos [3 ]
Flannery, Alexander [2 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] Univ Kentucky, Coll Pharm, Lexington, KY USA
[3] Univ Kentucky HealthCare, Lexington, KY USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
42
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] AKI IN SICU PATIENTS ON VANCOMYCIN/PIPERACILLIN-TAZOBACTAM VERSUS VANCOMYCIN/CEFEPIME OR MEROPENEM
    Nardone, Alexa
    Droege, Chris
    Hammond, Drayton
    Schrager, Jason
    Mueller, Eric
    CRITICAL CARE MEDICINE, 2019, 47
  • [2] NEPHROTOXICITY WITH VANCOMYCIN IN COMBINATION WITH PIPERACILLIN-TAZOBACTAM OR CEFEPIME/MEROPENEM
    Buckley, Mitchell
    Komerdelj, Ivan
    D'Alessio, Paul
    Tinta, Nicole
    Rangan, Pooja
    Yerondopoulos, Melanie
    Kobic, Emir
    Martinez, Brandon
    Ziadat, Delia
    Kane-Gill, Sandra
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 441 - 441
  • [3] VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM COMPARED TO VANCOMYCIN AND CEFEPIME IN ACUTE KIDNEY INJURY
    Barre, Stephanie
    Samarin, Michael
    Jacobs, Anna
    Krushinski, Joseph
    CRITICAL CARE MEDICINE, 2020, 48
  • [4] Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
    Rutter, W. Cliff
    Cox, Jessica N.
    Martin, Craig A.
    Burgess, Donna R.
    Burgess, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)
  • [5] AKI RATES WITH VANCOMYCIN AND CONCOMITANT PIPERACILLIN/TAZOBACTAM OR CEFEPIME IN THE ICU
    Buckley, Mitchell
    Hartsock, Nicole
    Berry, Andrew
    Bikin, Dale
    Hammond, Drayton
    Richards, Emily
    Yerondopoulos, Melanie
    Kobic, Emir
    Wicks, Laura
    CRITICAL CARE MEDICINE, 2019, 47
  • [6] Evaluation of the Risk of Acute Kidney Injury (AKI) Associated With Vancomycin Plus Piperacillin-Tazobactam (VPT) Compared With Vancomycin Plus Cefepime (VC)
    Jeon, Nakyung
    Staley, Ben
    Klinker, Kenneth P.
    Ghandi, Aakash B.
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 270 - 270
  • [7] Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime
    Chanderraj, Rishi
    Admon, Andrew J.
    He, Ying
    Nuppnau, Mark
    Albin, Owen R.
    Prescott, Hallie C.
    Dickson, Robert P.
    Sjoding, Michael W.
    JAMA INTERNAL MEDICINE, 2024, 184 (07) : 769 - 777
  • [8] Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime
    Moenster, R. P.
    Linneman, T. W.
    Finnegan, P. M.
    Hand, S.
    Thomas, Z.
    McDonald, J. R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : O384 - O389
  • [9] INCIDENCE OF AKI IN PATIENTS RECEIVING VANCOMYCIN WITH PIPERACILLIN-TAZOBACTAM OR B-LACTAM
    Santoriello, Lisa
    O'Donohue, Paul
    Chu, Alex
    Maisch, Nicole
    Smith, Candace
    Wu, Wenchen
    Barrera, Rafael
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 331 - 331
  • [10] ANTISTAPHYLOCOCCAL EFFICACY OF CEFEPIME, PIPERACILLIN-TAZOBACTAM, AND MEROPENEM
    Subedi, Bibidh
    Najia, Laila
    Pyles, Eric
    Ruiz, Arnaldo Lopez
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 337 - 337
12345